ICON plc to acquire CRO PRA Health Sciences for $12bn
ICON plc, an Ireland-based contract research organization (CRO), has agreed to acquire PRA Health Sciences in a cash-cum-stock deal worth around $12 billion. PRA Health ... Read More
Day One Biopharmaceuticals, Merck sign licensing deal for MEK Inhibitors
Day One Biopharmaceuticals has signed a licensing agreement with Merck to develop and commercialize pimasertib and MSC2015103B, two oral, small molecule allosteric inhibitors of MEK ... Read More
Regor Therapeutics raises $90m for CARD platform in Series B funding round
Regor Therapeutics has raised $90 million in a Series B financing round towards the discovery and development of discovery of drugs for cancer, immune disorders, and metabolic ... Read More
Bharat Forge, Paramount to manufacture Kalyani M4 armoured vehicles in India
Bharat Forge has entered into a partnership with Paramount Group for manufacturing the Kalyani M4 armoured vehicles in India. In this regard, the Indian engineering ... Read More
Dr. Reddy’s seeks EUA for Russian Covid-19 vaccine Sputnik V from DCGI
Dr. Reddy’s Laboratories said that it has started the process to seek the emergency use authorization (EUA) for the Russian Covid-19 vaccine Sputnik V from ... Read More
Altasciences acquires California-based CRO WCCT Global
Altasciences has acquired WCCT Global, an early stage clinical research organization (CRO) based in Southern California, for an undisclosed price. The Canada-based mid-size CRO/CDMO said ... Read More
TfNSW to award $1.2bn Country Regional Network contract to UGL
The Transport for New South Wales (TfNSW) has confirmed CIMIC Group company as the successful bidder for the operation and maintenance of rail infrastructure for ... Read More
ADB grants $25m to Philippine govt for procuring COVID-19 vaccines
The Asian Development Bank (ADB) has sanctioned $25 million to help the government of the Philippines to buy COVID-19 vaccines in 2021. The financing is ... Read More
ForDoz Pharma to manufacture LipoMedix’ oncology candidate Promitil
New Jersey-based ForDoz Pharma has signed an agreement with LipoMedix for manufacturing the latter’s lead compound - pegylated liposomal Promitil (PL-MLP) for a phase 2 ... Read More
Dr. Reddy’s Laboratories launches Fluphenazine Hydrochloride Tablets in US
Dr. Reddy’s Laboratories, an Indian pharma company, has launched Fluphenazine Hydrochloride Tablets, USP, in the US market. Fluphenazine Hydrochloride Tablets, USP is a therapeutic equivalent ... Read More